Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $1.42 USD
Change Today -0.2098 / -12.87%
Volume 416.1K
DSKX On Other Exchanges
As of 8:10 PM 05/4/15 All times are local (Market data is delayed by at least 15 minutes).

ds healthcare group inc (DSKX) Snapshot

Previous Close
Day High
Day Low
52 Week High
06/17/14 - $2.05
52 Week Low
12/22/14 - $0.56
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for DS HEALTHCARE GROUP INC (DSKX)

Related News

No related news articles were found.

ds healthcare group inc (DSKX) Related Businessweek News

No Related Businessweek News Found

ds healthcare group inc (DSKX) Details

DS Healthcare Group, Inc., doing business as DS Laboratories, develops and markets hair care, skin care, and personal care products in North America and internationally. Its hair care products include Revita and Revita LT shampoos, and Revita.Cor conditioner for hair growth stimulation; Dandrene, an antifungal shampoo to treat itchy scalp and dandruff; and Spectral line of products comprising Spectral.DNC spray formula, Spectral.DNC-L lotion, and Spectral DNC-N to re-grow hair through various pathways, as well as Spectral.RS, a topical treatment for men and women with advanced androgenic alopecia. The company’s skin care products comprise Hydroviton, a skin cleanser for oily and acne prone skin; Keramene, which is used to suppress hair growth and soften remaining hair strands; Oligo.DX, a cream to enhance the appearance of cellulite from women’s thighs, hips, and buttocks; and Trioxil, an acne cream. Its personal care products consist of Nirena, an intimate feminine care cleanser; and Spectral Lash, a product based on advanced bio-peptides that are designed to grow and enhance the length and girth of eyelash hair. DS Healthcare Group, Inc. markets and sells its products under the DS Laboratories, Polaris Labs, and Sigma Skin brands through salons, spas, department stores, specialty retailers, and distributors. The company was formerly known as Divine Skin, Inc. and changed its name to DS Healthcare Group, Inc. in November 2012. DS Healthcare Group, Inc. is headquartered in Pompano Beach, Florida.

46 Employees
Last Reported Date: 04/15/15

ds healthcare group inc (DSKX) Top Compensated Officers

Chairman, Chief Executive Officer, President,...
Total Annual Compensation: $169.9K
Compensation as of Fiscal Year 2013.

ds healthcare group inc (DSKX) Key Developments

DS Healthcare Group, Inc. Announces Board Changes

Effective April 29, 2015 Matthew Pfeffer resigned as director of DS Healthcare Group, Inc. Mr. Pfeffer has not expressed any disagreement with the company on any matter relating to the company's operations, policies or practices. Mr. Pope, a current director of the company, has been appointed to serve as the company's Audit Committee chairman following Mr. Pfeffer's resignation. Effective April 29, 2015, the board of directors appointed Michael Pope to fill the recently created vacancy on the company's board of directors. Mr. Pope shall also serve on the company's audit, compensation and nominating committees. Mr. Pope has served as managing director of Vert Capital Corp., since October 2011.

DS Healthcare Group Regains Compliance With NASDAQ Listing Requirements

DS Healthcare Group, Inc. announced that it has regained compliance with the listing requirements of the NASDAQ Capital Market. As previously reported, on December 16, 2014, NASDAQ notified the Company that its common stock was not in listing compliance as it failed to maintain a minimum bid price of $1.00 over the previous 30 consecutive business days as required by NASDAQ's listing rules. On April 29, 2015, the Company received a notice from the NASDAQ indicating that since the closing bid price of the Company's common stock had been at $1.00 per share or greater for the last 10 consecutive business days, the Company has regained compliance with Listing Rule 5550(a)(2) and this matter is now closed.

DS Healthcare Group, Inc. Begins Shipping Continuum on April 24, 2015 to Distributors in United State and Abroad

DS Healthcare Group, Inc. announced that Continuum, the latest addition to its existing product portfolio would begin shipping on April 24, 2015 to distributors in the United States and abroad. Continuum is a three-step treatment that includes Ro-Maxx Quantum Creator, Ro-Zen Quantum Optimizer, and Ro-Topia Fractal Energizer. This treatment was developed due to the tremendous demand for professional services designed to protect one's hair during bleaching and coloring, which represents a multi-billion dollar services industry. A chemical reaction which occurs during bleaching or coloring opens the cuticle and oxidizes melanin to help remove pigment, but can also leave hair structurally damaged. Continuum is a completely new innovation assembled with the use of proprietary technology developed by DS Healthcare, which instantly repairs hair strands and restores hair to its optimal state within minutes.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DSKX:US $1.42 USD -0.2098

DSKX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Johnson & Johnson $100.35 USD +0.22
Procter & Gamble Co/The $80.35 USD +0.06
View Industry Companies

Industry Analysis


Industry Average

Valuation DSKX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.0x
Price/Book 5.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.9x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DS HEALTHCARE GROUP INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at